TFF Group (EPA:TFF)
17.80
-0.20 (-1.11%)
Mar 6, 2026, 11:02 AM CET
TFF Group Employees
TFF Group had 1,575 employees as of April 30, 2025. The number of employees decreased by 82 or -4.95% compared to the previous year.
Employees
1,575
Change (1Y)
-82
Growth (1Y)
-4.95%
Revenue / Employee
€232,472
Profits / Employee
€14,805
Market Cap
390.24M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| LVMH Moët Hennessy - Louis Vuitton, Société Européenne | 196,647 |
| Hermès International Société en commandite par actions | 26,494 |
| Christian Dior SE | 211,000 |
| Kering | 43,731 |
| Bénéteau | 6,419 |
| SMCP S.A. | 6,404 |
| Groupe Guillin | 3,663 |
| Aramis Group SAS | 2,383 |
TFF Group News
- 1 year ago - TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration - PRNewsWire
- 1 year ago - TFF Pharmaceuticals Announces It Will Wind Down Operations - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing - GlobeNewsWire